{
  "fullName": "Bongani Mayosi",
  "slug": "bongani-mayosi",
  "title": "MD",
  "specialty": "Cardiology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 103,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Bongani Mawethu Mayosi was a South African professor of cardiology He was the Dean of the Faculty of Health Sciences at the University of Cape Town and an A-rated National Research Foundation researcher. Prior to this, he was head of the Department of Medicine at the University of Cape Town and Groote Schuur Hospital. His research interests included rheumatic fever, tuberculous pericarditis and cardiomyopathy. He was a member of the Academy of Science of South Africa and a former President of the College of Physicians of South Africa and he headed numerous other biomedical organisations during his career.",
  "aiSummary": "Bongani Mayosi is a cardiology specialist with an H-index of 103 at University of Cape Town (Member). Has been published in Science, Nature Medicine, New England Journal of Medicine. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "University of Cape Town"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "University of Cape Town",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Cardiology"
  ],
  "knowsAbout": [
    "Order of Mapungubwe"
  ],
  "citations": [
    {
      "title": "Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy",
      "journal": "Science",
      "year": 1997,
      "citationCount": 3080,
      "doi": "10.1126/science.278.5341.1295",
      "sourceUrl": "https://doi.org/10.1126/science.278.5341.1295",
      "verified": true
    },
    {
      "title": "Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy",
      "journal": "Nature Medicine",
      "year": 1999,
      "citationCount": 2123,
      "doi": "10.1038/8394",
      "sourceUrl": "https://doi.org/10.1038/8394",
      "verified": true
    },
    {
      "title": "Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis",
      "journal": "Clinical Infectious Diseases",
      "year": 2016,
      "citationCount": 1413,
      "doi": "10.1093/cid/ciw376",
      "sourceUrl": "https://doi.org/10.1093/cid/ciw376",
      "verified": true
    },
    {
      "title": "Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection",
      "journal": "New England Journal of Medicine",
      "year": 2011,
      "citationCount": 941,
      "doi": "10.1056/nejmoa1104875",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1104875",
      "verified": true
    },
    {
      "title": "Tuberculosis and diabetes mellitus: convergence of two epidemics",
      "journal": "The Lancet Infectious Diseases",
      "year": 2009,
      "citationCount": 930,
      "doi": "10.1016/s1473-3099(09)70282-8",
      "sourceUrl": "https://doi.org/10.1016/s1473-3099(09)70282-8",
      "verified": true
    },
    {
      "title": "Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions",
      "journal": "Annals of Internal Medicine",
      "year": 1999,
      "citationCount": 853,
      "doi": "10.7326/0003-4819-131-2-199907200-00002",
      "sourceUrl": "https://doi.org/10.7326/0003-4819-131-2-199907200-00002",
      "verified": true
    },
    {
      "title": "Latent <i>Mycobacterium tuberculosis</i> Infection",
      "journal": "New England Journal of Medicine",
      "year": 2015,
      "citationCount": 737,
      "doi": "10.1056/nejmra1405427",
      "sourceUrl": "https://doi.org/10.1056/nejmra1405427",
      "verified": true
    },
    {
      "title": "Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco",
      "journal": "JAMA",
      "year": 1989,
      "citationCount": 581,
      "doi": "10.1001/jama.1989.03420040099027",
      "sourceUrl": "https://doi.org/10.1001/jama.1989.03420040099027",
      "verified": true
    },
    {
      "title": "Management of latent<i>Mycobacterium tuberculosis</i>infection: WHO guidelines for low tuberculosis burden countries",
      "journal": "European Respiratory Journal",
      "year": 2015,
      "citationCount": 567,
      "doi": "10.1183/13993003.01245-2015",
      "sourceUrl": "https://doi.org/10.1183/13993003.01245-2015",
      "verified": true
    },
    {
      "title": "Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort",
      "journal": "BMJ",
      "year": 1988,
      "citationCount": 548,
      "doi": "10.1136/bmj.296.6624.745",
      "sourceUrl": "https://doi.org/10.1136/bmj.296.6624.745",
      "verified": true
    },
    {
      "title": "Incidence and Natural History of Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Disease Treated with Zidovudine",
      "journal": "The Journal of Infectious Diseases",
      "year": 1992,
      "citationCount": 531,
      "doi": "10.1093/infdis/166.6.1223",
      "sourceUrl": "https://doi.org/10.1093/infdis/166.6.1223",
      "verified": true
    },
    {
      "title": "Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections",
      "journal": "Hepatology",
      "year": 2002,
      "citationCount": 521,
      "doi": "10.1053/jhep.2002.30319",
      "sourceUrl": "https://doi.org/10.1053/jhep.2002.30319",
      "verified": true
    },
    {
      "title": "Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis",
      "journal": "New England Journal of Medicine",
      "year": 2021,
      "citationCount": 519,
      "doi": "10.1056/nejmoa2033400",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2033400",
      "verified": true
    },
    {
      "title": "Treatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus Infection",
      "journal": "New England Journal of Medicine",
      "year": 1991,
      "citationCount": 480,
      "doi": "10.1056/nejm199101313240503",
      "sourceUrl": "https://doi.org/10.1056/nejm199101313240503",
      "verified": true
    },
    {
      "title": "Tuberculosis in Patients with the Acquired Immunodeficiency Syndrome: Clinical Features, Response to Therapy, and Survival",
      "journal": "American Review of Respiratory Disease",
      "year": 1987,
      "citationCount": 458,
      "doi": "10.1164/ajrccm/136.3.570",
      "sourceUrl": "https://doi.org/10.1164/ajrccm/136.3.570",
      "verified": true
    },
    {
      "title": "Natural history of HIV infection in the_era of combination antiretroviral therapy",
      "journal": "AIDS",
      "year": 1999,
      "citationCount": 454,
      "doi": "10.1097/00002030-199910010-00017",
      "sourceUrl": "https://doi.org/10.1097/00002030-199910010-00017",
      "verified": true
    },
    {
      "title": "Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa",
      "journal": "JAIDS Journal of Acquired Immune Deficiency Syndromes",
      "year": 2009,
      "citationCount": 447,
      "doi": "10.1097/qai.0b013e318199072e",
      "sourceUrl": "https://doi.org/10.1097/qai.0b013e318199072e",
      "verified": true
    },
    {
      "title": "Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial",
      "journal": "The Lancet",
      "year": 2002,
      "citationCount": 408,
      "doi": "10.1016/s0140-6736(02)09742-8",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(02)09742-8",
      "verified": true
    },
    {
      "title": "Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis",
      "journal": "PLoS Medicine",
      "year": 2012,
      "citationCount": 400,
      "doi": "10.1371/journal.pmed.1001270",
      "sourceUrl": "https://doi.org/10.1371/journal.pmed.1001270",
      "verified": true
    },
    {
      "title": "Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS",
      "journal": "New England Journal of Medicine",
      "year": 1993,
      "citationCount": 395,
      "doi": "10.1056/nejm199309163291202",
      "sourceUrl": "https://doi.org/10.1056/nejm199309163291202",
      "verified": true
    },
    {
      "title": "Adherence to Nonnucleoside Reverse Transcriptase Inhibitorâ€“Based HIV Therapy and Virologic Outcomes",
      "journal": "Annals of Internal Medicine",
      "year": 2007,
      "citationCount": 386,
      "doi": "10.7326/0003-4819-146-8-200704170-00007",
      "sourceUrl": "https://doi.org/10.7326/0003-4819-146-8-200704170-00007",
      "verified": true
    },
    {
      "title": "New Regimens to Prevent Tuberculosis in Adults with HIV Infection",
      "journal": "New England Journal of Medicine",
      "year": 2011,
      "citationCount": 378,
      "doi": "10.1056/nejmoa1005136",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1005136",
      "verified": true
    },
    {
      "title": "Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community",
      "journal": "New England Journal of Medicine",
      "year": 1994,
      "citationCount": 366,
      "doi": "10.1056/nejm199403173301107",
      "sourceUrl": "https://doi.org/10.1056/nejm199403173301107",
      "verified": true
    },
    {
      "title": "Building a tuberculosis-free world: The Lancet Commission on tuberculosis",
      "journal": "The Lancet",
      "year": 2019,
      "citationCount": 350,
      "doi": "10.1016/s0140-6736(19)30024-8",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(19)30024-8",
      "verified": true
    },
    {
      "title": "One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis",
      "journal": "New England Journal of Medicine",
      "year": 2019,
      "citationCount": 343,
      "doi": "10.1056/nejmoa1806808",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1806808",
      "verified": true
    },
    {
      "title": "Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 Infection",
      "journal": "JAIDS Journal of Acquired Immune Deficiency Syndromes",
      "year": 2001,
      "citationCount": 337,
      "doi": "10.1097/00126334-200107010-00006",
      "sourceUrl": "https://doi.org/10.1097/00126334-200107010-00006",
      "verified": true
    },
    {
      "title": "Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic",
      "journal": "AIDS",
      "year": 2002,
      "citationCount": 321,
      "doi": "10.1097/00002030-200203290-00012",
      "sourceUrl": "https://doi.org/10.1097/00002030-200203290-00012",
      "verified": true
    },
    {
      "title": "Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis",
      "journal": "American Journal of Respiratory and Critical Care Medicine",
      "year": 2003,
      "citationCount": 315,
      "doi": "10.1164/rccm.200310-1380oc",
      "sourceUrl": "https://doi.org/10.1164/rccm.200310-1380oc",
      "verified": true
    },
    {
      "title": "Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis",
      "journal": "Clinical Infectious Diseases",
      "year": 2016,
      "citationCount": 310,
      "doi": "10.1093/cid/ciw566",
      "sourceUrl": "https://doi.org/10.1093/cid/ciw566",
      "verified": true
    },
    {
      "title": "The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil",
      "journal": "AIDS",
      "year": 2007,
      "citationCount": 306,
      "doi": "10.1097/qad.0b013e328216f441",
      "sourceUrl": "https://doi.org/10.1097/qad.0b013e328216f441",
      "verified": true
    },
    {
      "title": "Race, Sex, Drug Use, and Progression of Human Immunodeficiency Virus Disease",
      "journal": "New England Journal of Medicine",
      "year": 1995,
      "citationCount": 299,
      "doi": "10.1056/nejm199509213331202",
      "sourceUrl": "https://doi.org/10.1056/nejm199509213331202",
      "verified": true
    },
    {
      "title": "Active case finding of tuberculosis: historical perspective and future prospects.",
      "journal": "PubMed",
      "year": 2005,
      "citationCount": 296,
      "doi": null,
      "sourceUrl": "https://openalex.org/W1234345268",
      "verified": true
    },
    {
      "title": "Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial",
      "journal": "The Lancet",
      "year": 2009,
      "citationCount": 292,
      "doi": "10.1016/s0140-6736(09)60333-0",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(09)60333-0",
      "verified": true
    },
    {
      "title": "Zidovudine and the Natural History of the Acquired Immunodeficiency Syndrome",
      "journal": "New England Journal of Medicine",
      "year": 1991,
      "citationCount": 286,
      "doi": "10.1056/nejm199105163242006",
      "sourceUrl": "https://doi.org/10.1056/nejm199105163242006",
      "verified": true
    },
    {
      "title": "Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis",
      "journal": "American Journal of Respiratory and Critical Care Medicine",
      "year": 2006,
      "citationCount": 284,
      "doi": "10.1164/rccm.200603-360oc",
      "sourceUrl": "https://doi.org/10.1164/rccm.200603-360oc",
      "verified": true
    },
    {
      "title": "Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco.",
      "journal": "American Journal of Public Health",
      "year": 1987,
      "citationCount": 279,
      "doi": "10.2105/ajph.77.2.169",
      "sourceUrl": "https://doi.org/10.2105/ajph.77.2.169",
      "verified": true
    },
    {
      "title": "Adherence to Antiretroviral and Pneumocystis Prophylaxis in HIV Disease",
      "journal": "Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology",
      "year": 1998,
      "citationCount": 279,
      "doi": "10.1097/00042560-199806010-00003",
      "sourceUrl": "https://doi.org/10.1097/00042560-199806010-00003",
      "verified": true
    },
    {
      "title": "Adherence to Highly Active Antiretroviral Therapy Assessed by Pharmacy Claims Predicts Survival in HIV-Infected South African Adults",
      "journal": "JAIDS Journal of Acquired Immune Deficiency Syndromes",
      "year": 2006,
      "citationCount": 274,
      "doi": "10.1097/01.qai.0000225015.43266.46",
      "sourceUrl": "https://doi.org/10.1097/01.qai.0000225015.43266.46",
      "verified": true
    },
    {
      "title": "Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection",
      "journal": "The Lancet",
      "year": 1998,
      "citationCount": 272,
      "doi": "10.1016/s0140-6736(97)06532-x",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(97)06532-x",
      "verified": true
    },
    {
      "title": "Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis",
      "journal": "American Journal of Respiratory and Critical Care Medicine",
      "year": 2009,
      "citationCount": 264,
      "doi": "10.1164/rccm.200901-0078oc",
      "sourceUrl": "https://doi.org/10.1164/rccm.200901-0078oc",
      "verified": true
    },
    {
      "title": "Human Immunodeficiency Virus Infection in Tuberculosis Patients",
      "journal": "The Journal of Infectious Diseases",
      "year": 1990,
      "citationCount": 249,
      "doi": "10.1093/infdis/162.1.8",
      "sourceUrl": "https://doi.org/10.1093/infdis/162.1.8",
      "verified": true
    },
    {
      "title": "Adherence to Antiretroviral Therapy in HIV-Infected Adults in Soweto, South Africa",
      "journal": "AIDS Research and Human Retroviruses",
      "year": 2004,
      "citationCount": 234,
      "doi": "10.1089/aid.2004.20.1053",
      "sourceUrl": "https://doi.org/10.1089/aid.2004.20.1053",
      "verified": true
    },
    {
      "title": "Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort",
      "journal": "AIDS",
      "year": 2009,
      "citationCount": 231,
      "doi": "10.1097/qad.0b013e328327964f",
      "sourceUrl": "https://doi.org/10.1097/qad.0b013e328327964f",
      "verified": true
    },
    {
      "title": "Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy",
      "journal": "The Lancet Infectious Diseases",
      "year": 2004,
      "citationCount": 231,
      "doi": "10.1016/s1473-3099(04)01130-2",
      "sourceUrl": "https://doi.org/10.1016/s1473-3099(04)01130-2",
      "verified": true
    },
    {
      "title": "A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control",
      "journal": "New England Journal of Medicine",
      "year": 2014,
      "citationCount": 227,
      "doi": "10.1056/nejmoa1214289",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1214289",
      "verified": true
    },
    {
      "title": "Tuberculosis Drug Resistance: A Global Threat",
      "journal": "Clinical Infectious Diseases",
      "year": 2003,
      "citationCount": 224,
      "doi": "10.1086/344657",
      "sourceUrl": "https://doi.org/10.1086/344657",
      "verified": true
    },
    {
      "title": "Tuberculosis and Human Immunodeficiency Virus Infection",
      "journal": "The Journal of Infectious Diseases",
      "year": 1989,
      "citationCount": 223,
      "doi": "10.1093/infdis/159.1.96",
      "sourceUrl": "https://doi.org/10.1093/infdis/159.1.96",
      "verified": true
    },
    {
      "title": "Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis",
      "journal": "American Journal of Respiratory and Critical Care Medicine",
      "year": 2004,
      "citationCount": 221,
      "doi": "10.1164/rccm.200407-885oc",
      "sourceUrl": "https://doi.org/10.1164/rccm.200407-885oc",
      "verified": true
    },
    {
      "title": "Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection",
      "journal": "The Lancet",
      "year": 2015,
      "citationCount": 215,
      "doi": "10.1016/s0140-6736(15)00323-2",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(15)00323-2",
      "verified": true
    },
    {
      "title": "Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.",
      "journal": "PubMed",
      "year": 1999,
      "citationCount": 215,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2656264",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5071106707"
}